Posts by ericg
Cambridge biotech’s plan to merge with Trump commerce secretary’s SPAC falls apart
A Cambridge biotech’s plan to merge with a special-purpose acquisition company, or SPAC, sponsored by the former U.S. commerce secretary under President Donald Trump has fallen apart. Read More
Read MoreMBTA to shut down sections of Red Line in October to replace aging tracks
The MBTA will fully close two southern sections of the Red Line for 16 days in October, during which General Manager Phil Eng said workers will replace some of the oldest track in the T’s system. Read More
Read MoreCVS launches Cordavis to market biosimilars
Cordavis’ first product will be Hyrimoz, a private-label drug with an 80% lower list price than Humira, CVS said. Read More
Read MoreSteward proposes new $77M behavioral health facility at Good Samaritan Medical Center in Brockton
Steward plans to relocate the inpatient psychiatric beds that closed when Norwood Hospital flooded to a new four-story behavioral health facility at Good Samaritan Medical Center. Read More
Read MoreSharkNinja CEO addresses possible reinstatement of China tariffs
One of the Bay State’s newest public companies is facing an old threat looming on many consumer companies that import goods from China: the potential reinstatement of the punitive fees that were first imposed by the Trump administration in 2018. Read More
Read MoreBe careful asking ChatGPT questions about cancer treatment, Brigham study says
When prompted with questions about cancer treatment, ChatGPT 3.5 gave incorrect recommendations at times, which could be misleading to patients, Brigham researchers reported. Read More
Read MoreNasuni named its first chief innovation officer. Here’s what that means in the age of AI.
Jim Liddle spoke to BostInno about what it means to be a chief innovation officer in 2023, the prevalence of AI in data services and taking Nasuni’s data intelligence work up a notch. Read More
Read MoreFive things you need to know, and Toast’s recipe for success
Here are the five things you need to know today, from a Watertown biotech’s accidental boost to a Lexington biotech’s bad news, plus two colleges’ move to D1, a new Everett project and why Toast is coming up golden. Read More
Read MoreAdvanced AI prompts new questions over intellectual property
We asked intellectual property attorneys in Boston for their thoughts on who should get credit for work created through generative AI. Read More
Read MoreThe Petri Dish: Selecta gets selective with drug programs; Moderna enters 2nd cancer vaccine collab
A Watertown biotech trimmed its pipeline again, setting aside all of its experimental drugs except one. It’s the second time the company has cut programs this year. Plus other life sciences news you may have missed. Read More
Read More